230 related articles for article (PubMed ID: 28852126)
1. Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.
Chiou J; Su CY; Jan YH; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2017 Aug; 7(1):9830. PubMed ID: 28852126
[TBL] [Abstract][Full Text] [Related]
2. Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway.
Jin X; Nie E; Zhou X; Zeng A; Yu T; Zhi T; Jiang K; Wang Y; Zhang J; You Y
Cell Physiol Biochem; 2017; 44(4):1616-1628. PubMed ID: 29212066
[TBL] [Abstract][Full Text] [Related]
3. Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development.
Geng Y; Dong Y; Yu M; Zhang L; Yan X; Sun J; Qiao L; Geng H; Nakajima M; Furuichi T; Ikegawa S; Gao X; Chen YG; Jiang D; Ning W
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7058-63. PubMed ID: 21482757
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
Chiou J; Chang YC; Tsai HF; Lin YF; Huang MS; Yang CJ; Hsiao M
Cancer Res; 2019 Dec; 79(24):6113-6125. PubMed ID: 31653686
[TBL] [Abstract][Full Text] [Related]
5. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.
Lau MC; Ng KY; Wong TL; Tong M; Lee TK; Ming XY; Law S; Lee NP; Cheung AL; Qin YR; Chan KW; Ning W; Guan XY; Ma S
Cancer Res; 2017 Nov; 77(21):5886-5899. PubMed ID: 28883005
[TBL] [Abstract][Full Text] [Related]
6. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Tgfbr2/ERK-Smad4/SOX2 Signaling Promotes Lung Squamous Cell Carcinoma Formation.
Wang Y; Tan X; Tang Y; Zhang C; Xu J; Zhou J; Cheng X; Hou N; Liu W; Yang G; Teng Y; Yang X
Cancer Res; 2019 Sep; 79(17):4466-4479. PubMed ID: 31209059
[TBL] [Abstract][Full Text] [Related]
8. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β - dependent manner in hepatocellular carcinoma.
Yang W; Wu Y; Wang C; Liu Z; Xu M; Zheng X
Cancer Biomark; 2017 Jul; 20(1):75-85. PubMed ID: 28655132
[TBL] [Abstract][Full Text] [Related]
9. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
Yu C; Hou L; Cui H; Zhang L; Tan X; Leng X; Li Y
Future Oncol; 2018 Oct; 14(24):2483-2492. PubMed ID: 29756998
[TBL] [Abstract][Full Text] [Related]
10. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
11. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis.
Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J
Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795
[TBL] [Abstract][Full Text] [Related]
13. High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy.
Hai Y; Chen N; Wu W; Wang Z; Lin F; Guo C; Liu C; Li W; Liu L
BMC Cancer; 2018 Oct; 18(1):1011. PubMed ID: 30348119
[TBL] [Abstract][Full Text] [Related]
14. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
Kaishang Z; Xue P; Shaozhong Z; Yingying F; Yan Z; Chanjun S; Zhenzhen L; Xiangnan L
Life Sci; 2018 Dec; 215():159-169. PubMed ID: 30391462
[TBL] [Abstract][Full Text] [Related]
15. FSTL1 suppresses tumor cell proliferation, invasion and survival in non-small cell lung cancer.
Ni X; Cao X; Wu Y; Wu J
Oncol Rep; 2018 Jan; 39(1):13-20. PubMed ID: 29115636
[TBL] [Abstract][Full Text] [Related]
16. Isoform specific gene expression analysis of KRAS in the prognosis of lung adenocarcinoma patients.
Yang IS; Kim S
BMC Bioinformatics; 2018 Feb; 19(Suppl 1):40. PubMed ID: 29504894
[TBL] [Abstract][Full Text] [Related]
17.
Yu J; Hou M; Pei T
DNA Cell Biol; 2020 May; 39(5):890-899. PubMed ID: 32282228
[TBL] [Abstract][Full Text] [Related]
18. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
19. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
20. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.
Bae K; Park KE; Han J; Kim J; Kim K; Yoon KA
Oncotarget; 2016 Apr; 7(14):18076-84. PubMed ID: 26716515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
